PE:
ECG:
TTE: EF, RWMA, no root dilatation/flap/AR, no pericardial effusion
CXR:
Lab: LA, TnT
. Loading DAPT (aspirin 300mg + brilinta 180mg)
. Heparinization (Loading dose 60U/kg, max 4000U, maintenance dose 12U/kg/hr)
. Primary PCI then CCU admission
. f/u ECG and TnT Q6H until peaking
. Inform MACE and bleeding risk
. Check 4 limb BP for complaining back pain
. Risk stratification: check lipid profile, HbA1c, lipoprotein (a)
. Optimize medical therapy including beta blocker, ACEI/ARB and high intensity statin as tolerated
. Heparinization (Loading dose 60U/kg, max 4000U, maintenance dose 12U/kg/hr)
. Primary PCI then CCU admission
. f/u ECG and TnT Q6H until peaking
. Inform MACE and bleeding risk
. Check 4 limb BP for complaining back pain
. Risk stratification: check lipid profile, HbA1c, lipoprotein (a)
. Optimize medical therapy including beta blocker, ACEI/ARB and high intensity statin as tolerated
[PE]
E4V5M6
HEENT: Pink conjunctiva, anicteric sclera
Heart: Regular heart beat without murmur
Chest: bilateral clear breath sounds
Abdomen: Soft and flat, normoactive bowel sounds
Extremities: No pitting edema
Skin: no ecchymoses. no rash
[CAD Risk factors]
DM(-), Hypertension(-), Dyslipidemia(-), Smoking(-), Sex(-), Age>45(men)(-), Age>55(woman or postmenopause)(-), Family history(male<55, female<65), Lack of exercise(-), obesity (-), Gout (-)